Half-year report · HY
9341.TEDINET S100X3YP
Period2025-04-01 → 2025-09-30
Filed2025-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.0bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥10.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | −¥37m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | −¥27m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.0bn | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | −¥23m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.2bn | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥14m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.4bn | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥815m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥14m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥815m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥10.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥8.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.4bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.5bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥6.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.4bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.4bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.9bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥89m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥589m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥687m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥276m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥232m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥259m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥336m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-0.8 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥79.78 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.79 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥79.02 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥45.44 | 2024-04-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 60.5% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.9% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥229m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥229m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | ¥35m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥1.0bn |
| Dental Distribution Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥736m |
| Dental Distribution Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥736m |
| Dental Distribution Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥60m |
| Dx Distribution Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥97m |
| Dx Distribution Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥97m |
| Dx Distribution Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥28m |
| Medical Platform Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.4bn |
| Medical Platform Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.4bn |
| Medical Platform Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥803m |
| Smart Clinic Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Smart Clinic Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Smart Clinic Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥175m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥4.7bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥4.7bn |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥947m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥5.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥981m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-04-01 → 2024-09-30 | ¥271m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-04-01 → 2024-09-30 | ¥271m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-04-01 → 2024-09-30 | ¥64m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2024-09-30 | −¥964m |
| Medical Platform Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Medical Platform Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥3.2bn |
| Medical Platform Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| Smart Clinic Businessreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| Smart Clinic Businessreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥1.7bn |
| Smart Clinic Businessreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥394m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥4.9bn |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥2.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 496
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)上西 貴之 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)山内 紀彰 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 5143392000 | JPY |
| Net sales (5-year summary) | InterimDuration | 4974745000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 10006101000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 1203405000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | -26619000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 2018024000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 814872000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | -13928000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 1413468000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 814638000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | -14013000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 1413609000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 6944451000 | JPY |
| Net assets (5-year summary) | InterimInstant | 6535430000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6998656000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 8594619000 | JPY |
| Total assets (5-year summary) | InterimInstant | 9968714000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 8526196000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 45.79 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | -0.80 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 79.78 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | 45.44 | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | 79.02 | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.767 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.605 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.769 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 588789000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | -88660000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 1194851000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -231985000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -686996000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -275933000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -335692000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | 258809000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -1014917000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 5986382000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 5355662000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 5872171000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17826600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 17826600 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 17826600 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 17826600 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 5602700 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.3234 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |